DXN — Dxn Income Statement
0.000.00%
- AU$9.28m
- AU$11.08m
- AU$11.25m
- 22
- 57
- 10
- 20
Annual income statement for Dxn, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | R2022 June 30th | R2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.26 | 8.23 | 15.2 | 7.75 | 11.3 |
Cost of Revenue | |||||
Gross Profit | 1.48 | 2.45 | 4.75 | 4.91 | 6.35 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 17.9 | 13 | 22.2 | 17.4 | 13.6 |
Operating Profit | -12.6 | -4.81 | -7.01 | -9.61 | -2.3 |
Net Income Before Taxes | -12.6 | -4.81 | -7.01 | -9.61 | -2.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12.6 | -4.81 | -7.01 | -9.61 | -2.3 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -12.6 | -4.81 | -6.9 | -9.61 | -2.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.6 | -4.81 | -6.9 | -9.61 | -2.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.277 | -0.112 | -0.076 | -0.049 | -0.015 |